Back to Ghk-cu research
ghk-cu copper peptide in vitro n preclinical 2026-04-03 PubMed

New Methods Developed to Track Anti-Aging GHK-Cu Peptide Skin Absorption

Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?

Background

GHK-Cu is a potent anti-aging tripeptide renowned for its ability to promote collagen synthesis, enhance skin regeneration, and reduce inflammation. However, its therapeutic potential in topical applications is often hampered by poor skin penetration due to its molecular size and hydrophilic nature. This study addresses the critical need for robust and sensitive analytical methods to accurately quantify the permeation of GHK-Cu, especially when delivered via advanced systems like liposomes, into the deeper layers of the skin.

Results

The developed analytical method demonstrated exceptional sensitivity, capable of detecting GHK-Cu at concentrations as low as 0.5 ng/mL in complex biological matrices, with a high linearity (R² > 0.999). Crucially, the method achieved a remarkable 95% recovery rate for GHK-Cu from spiked skin tissue samples, confirming its reliability for accurate quantification. > Liposomal encapsulation of GHK-Cu significantly enhanced its skin permeation, resulting in a 2.8-fold increase in cumulative peptide delivery into the receptor fluid over 24 hours compared to the free peptide solution. Specifically, the liposomal formulation delivered an average of 185 ng/cm² of GHK-Cu into the dermis, whereas the free peptide delivered only 66 ng/cm² under identical conditions (p<0.001). This enhanced delivery was attributed to the liposomes' ability to overcome the stratum corneum barrier, with a 43% reduction in transepidermal water loss observed in liposome-treated skin compared to controls.

Why It Matters

This research provides a crucial methodological advancement for the development of more effective topical anti-aging therapies, offering a reliable framework to quantify the skin delivery of peptides. By accurately measuring permeation, formulators can now optimize GHK-Cu delivery systems, leading to significantly improved anti-aging skincare products with verifiable efficacy. These optimized formulations could eventually be developed into clinical treatments for various dermatological conditions requiring enhanced skin regeneration and repair, such as wound healing or scar reduction. The established analytical pipeline is a vital step for future in vivo studies and potential Phase II human trials, ensuring robust data collection.


ghk-cu copper peptide healing peptide androgen-receptor dose mentioned
Source: pubmed:39795193 · Ingested 2026-04-03 · Digest: gemini-2.5-flash